Renal Cancer - Results from #1740

Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC. December 6, 2021

A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. December 6, 2021

Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks. December 3, 2021

Prediction of post radical nephrectomy complications based on patient comorbidity preoperatively. December 3, 2021

ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma. December 2, 2021

Novel cut-off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long-term, follow-up, retrospective study. December 2, 2021

Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature. December 1, 2021

Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma. December 1, 2021

Targeted Quantification of Carbon Metabolites Identifies Metabolic Progression Markers and an Undiagnosed Case of SDH-Deficient Clear Cell Renal Cell Carcinoma in a German Cohort. November 30, 2021

Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma. November 30, 2021

European Commission Approves KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) as First-Line Treatment for Adult Patients With Advanced Renal Cell Carcinoma November 29, 2021

A renal cell carcinoma tumorgraft platform to advance precision medicine. November 29, 2021

Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma. November 29, 2021

Early Clinical Experience with Cabozantinib for Advanced Renal Cell Carcinoma in the UK: Real-World Treatment Pathways and Clinical Outcomes. November 26, 2021

Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease. November 26, 2021

Clinicopathological and Preclinical Patient-Derived Model Studies Define High Expression of NRN1 as a Diagnostic and Therapeutic Target for Clear Cell Renal Cell Carcinoma. November 25, 2021

Active Surveillance of Renal Masses: The Role of Radiology. November 25, 2021

Disparities in the Treatment and Survival of Metastatic Renal Cell Carcinoma. November 24, 2021

Impact of comorbidity on renal cell carcinoma prognosis: a nationwide cohort study. November 24, 2021

Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial. November 23, 2021

Page 88 of 456